Enlivex Therapeutics
ENLV
ENLV
13 hedge funds and large institutions have $1.4M invested in Enlivex Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$282K | |
| 2 | +$36.1K | |
| 3 | +$16K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$202 |
Top Sellers
| 1 | -$129K | |
| 2 | -$46.7K | |
| 3 | -$36K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19K |
| 5 |
OC
Oppenheimer & Co
New York
|
-$18.9K |